Spotfire, Inc. has announced DecisionSite® for Microarray Analysis (DSMA), which gives drug makers a competitive advantage in quickly and accurately identifying potential drug targets. DSMA, available ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する